KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $53,949,000 | +34.0% | 771,250 | 0.0% | 4.15% | +28.9% |
| Q3 2021 | $40,267,000 | -24.8% | 771,250 | -2.1% | 3.22% | -34.8% |
| Q2 2021 | $53,576,000 | -22.3% | 787,876 | -12.0% | 4.94% | -10.7% |
| Q1 2021 | $68,951,000 | +28.4% | 895,000 | 0.0% | 5.53% | +33.7% |
| Q4 2020 | $53,700,000 | +39.4% | 895,000 | 0.0% | 4.14% | +19.5% |
| Q3 2020 | $38,530,000 | +3.9% | 895,000 | 0.0% | 3.46% | +6.3% |
| Q2 2020 | $37,071,000 | -4.2% | 895,000 | 0.0% | 3.26% | -25.8% |
| Q1 2020 | $38,700,000 | -21.9% | 895,000 | 0.0% | 4.39% | -47.2% |
| Q4 2019 | $49,565,000 | +59.5% | 895,000 | 0.0% | 8.31% | -14.4% |
| Q3 2019 | $31,079,000 | -13.8% | 895,000 | 0.0% | 9.72% | +5.2% |
| Q2 2019 | $36,042,000 | +25.2% | 895,000 | +2.3% | 9.24% | +33.3% |
| Q1 2019 | $28,788,000 | +58.3% | 875,000 | 0.0% | 6.93% | +47.7% |
| Q4 2018 | $18,183,000 | +65.5% | 875,000 | +40.0% | 4.69% | +133.2% |
| Q3 2018 | $10,988,000 | – | 625,000 | – | 2.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |